Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency
- PMID: 6522148
- DOI: 10.1203/00006450-198412000-00023
Biochemical studies of a patient with hereditary hepatorenal tyrosinemia: evidence of glutathione deficiency
Abstract
Metabolic and enzymatic studies in a patient with hereditary tyrosinemia demonstrated for the first time a deficiency of erythrocyte and hepatic glutathione. Markedly decreased hepatic fumarylacetoacetate hydrolase activity was demonstrated in this patient. The activities of hepatic enzymes not involved in tyrosine metabolism were also determined. Assay of mixed function oxidase activity demonstrated low levels of aryl hydrocarbon hydroxylase and 7-ethoxycoumarin deethylase, suggesting decreased hepatic detoxification capacity. 5-Aminolevulinic acid dehydratase activity was undetectable. Succinylacetone (4,6-dioxoheptanoic acid), an abnormal metabolic product secondary to fumarylacetoacetate hydrolase deficiency was found in serum and urine. Succinylacetone was demonstrated to inhibit 5-aminolevulinic acid dehydratase in vitro, as did the urine, plasma, and red cell lysates of the patient.
Similar articles
-
Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.J Clin Invest. 1983 Mar;71(3):625-34. doi: 10.1172/jci110809. J Clin Invest. 1983. PMID: 6826727 Free PMC article.
-
Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.Trans Assoc Am Physicians. 1982;95:42-52. Trans Assoc Am Physicians. 1982. PMID: 7182986
-
Biochemical studies on the enzymatic deficiencies in hereditary tyrosinemia.Clin Chim Acta. 1983 Oct 31;134(1-2):129-41. doi: 10.1016/0009-8981(83)90191-2. Clin Chim Acta. 1983. PMID: 6652907
-
Hepatorenal tyrosinemia.Proc Jpn Acad Ser B Phys Biol Sci. 2012;88(5):192-200. doi: 10.2183/pjab.88.192. Proc Jpn Acad Ser B Phys Biol Sci. 2012. PMID: 22687740 Free PMC article. Review.
-
Hereditary tyrosinemia type I--an overview.Scand J Clin Lab Invest Suppl. 1986;184:27-34. Scand J Clin Lab Invest Suppl. 1986. PMID: 3296130 Review.
Cited by
-
Deficient DNA-ligase activity in the metabolic disease tyrosinemia type I.Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12614-8. doi: 10.1073/pnas.95.21.12614. Proc Natl Acad Sci U S A. 1998. PMID: 9770534 Free PMC article.
-
Identification of Novel Mutations in FAH Gene and Prenatal Diagnosis of Tyrosinemia in Indian Family.Case Rep Genet. 2012;2012:428075. doi: 10.1155/2012/428075. Epub 2012 Oct 30. Case Rep Genet. 2012. PMID: 23193487 Free PMC article.
-
Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.J Clin Invest. 1992 Oct;90(4):1185-92. doi: 10.1172/JCI115979. J Clin Invest. 1992. PMID: 1401056 Free PMC article.
-
Clinical features and diagnostic approach in type I tyrosinaemia in an infant with cytomegaly virus infection and bacterial sepsis.Eur J Pediatr. 1993 Apr;152(4):327-30. doi: 10.1007/BF01956746. Eur J Pediatr. 1993. PMID: 8387006
-
Current strategies for the treatment of hereditary tyrosinemia type I.Paediatr Drugs. 2006;8(1):47-54. doi: 10.2165/00148581-200608010-00004. Paediatr Drugs. 2006. PMID: 16494511 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical